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Summary
Long-lasting changes in synaptic strength are thought
to play a pivotal role in activity-dependent plasticity
and memory. There is ample evidence indicating
that in hippocampal long-term potentiation (LTP) the
synthesis of new proteins is crucial for enduring
changes. However, whether protein degradation also
plays a role in this process has only recently begun
to receive attention. Here, we examine the effects of
blocking protein degradation on LTP. We show that
pharmacological inhibition of proteasome-dependent
protein degradation, just like inhibition of protein syn-
thesis, disrupts expression of late (L-)LTP. However,
when protein degradation and protein synthesis are
inhibited at the same time, LTP is restored to control
levels, calling into question the commonly held hy-
pothesis that synthesis of new proteins is indispens-
able for L-LTP. Instead, these findings point to a more
facetted model, in which L-LTP is determined by the
combined action of synthesis and degradation of plas-
ticity proteins.
Introduction
Synaptic plasticity is a multistep process that relies on
a variety of molecular changes at the synapse. These
changes include rapid posttranslational modifications
of proteins as well as alterations based on the regulation
of the availability of proteins and mRNAs. Whereas it is
well-documented that long-term changes in synaptic ef-
ficacy, such as late-phase LTP (L-LTP), can be blocked
by protein synthesis inhibitors (Frey et al., 1988; Huang
et al., 1996, but see also Fonseca et al., 2006), the role
of protein degradation in hippocampal LTP, which was
suggested as early as 1984 (Lynch and Baudry, 1984),
is only starting to be revealed. Protein ubiquitination
and subsequent proteasome-dependent degradation
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Oeiras, Portugal.provide a general mechanism by which proteins are
targeted for degradation or transiently sequestered
from the available functional pool (Ciechanover, 2005;
Hershko, 2005), allowing the cell to fine-tune protein
availability (for reviews in a neurobiological context,
see DiAntonio and Hicke, 2004; Bingol and Schuman,
2005; Yi and Ehlers, 2005; and Patrick, 2006). It has
been shown that proteasome inhibition can result in
an accumulation of proteins, such as Homer1a and
DUNC-13, which are known to be involved in synaptic
plasticity (Ageta et al., 2001a, 2001b; Ehlers, 2003;
Speese et al., 2003). This suggests that proteasome-
dependent protein degradation has the potential to
control the availability of proteins important for synap-
tic plasticity by counterbalancing protein synthesis,
thereby constraining synaptic enhancement.
Therefore, inhibiting protein degradation might be
expected to boost synaptic strengthening and its main-
tenance. This view is supported by a study of long-term
facilitation (LTF) inAplysia, in which chronic proteasome
inhibition increased LTF levels observed 24 hr later
(Zhao et al., 2003). However, evidence suggesting the
contrary in mammals was provided by a genetic study
showing that a mutation in a specific ubiquitin ligase re-
sults in impaired LTP and context-dependent learning
deficits (Jiang et al., 1998). Furthermore, it was shown
that proteasome inhibitors injected into the CA1 area
of the hippocampus cause retrograde amnesia for
one-trial inhibitory avoidance learning in rats, suggest-
ing that proper functioning of the ubiquitin-proteasome
system is required for hippocampus-dependent mem-
ory formation (Lopez-Salon et al., 2001).
We set out to study directly how acute manipulation of
protein turnover and protein degradation affects mam-
malian synaptic plasticity. For this, we investigated the
effects of pharmacological inhibition of protein synthe-
sis and proteasome blockade on LTP induced at
Schaffer collateral-CA1 synapses in the acute rat hippo-
campal slice preparation. We found that lactacystin and
epoxomicin, irreversible blockers of the proteasome,
specifically diminish the late phase of LTP, similar to
the effect of pharmacological blockade of translation.
Intriguingly, coapplication of either proteasome inhibitor
with blockers of protein synthesis largely restores L-LTP.
This suggests that interfering with either protein synthe-
sis or degradation upsets the balance of plasticity pro-
teins, which are upregulated after LTP induction and
required for the synaptic changes to endure, while block-
ing protein turnover altogether leaves L-LTP intact.
Results
Inhibition of Protein Degradation Diminishes
the Stability of LTP
To investigate the role of protein degradation for L-LTP,
LTP was induced at Schaffer collateral-CA1 synapses in
acute hippocampal slices in the presence of lactacystin
(10 nM), an irreversible inhibitor of the proteasome (Dick
et al., 1996). While this did not affect early LTP (E-LTP)
(Figure 1A; filled blue squares, lactacystin: 169% 6 6%,
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240Figure 1. L-LTP Depends on Intact Proteasome
(A) L-LTP was blocked by inhibition of proteasome-dependent pro-
tein degradation (10 nM lactacystin). fEPSPs were recorded at a fre-
quency of 0.1 Hz. LTP values for lactacystin-treated slices (filled blue
squares) were significantly lower than control values (filled black cir-
cles) at the end of the recording (140% 6 5%, n = 9, compared with
162% 6 4%, n = 30; p = 0.002; green triangles denote p values). A
second, independent control pathway was recorded simulta-
neously, showing no decrement in basal synaptic transmission
(open symbols). The green triangles denote p values (two-tailed Stu-
dent’s t test; control versus experimental situation) for 10 min data
bins (see Experimental Procedures). The insets show individual
fEPSP traces for lactacystin (blue) and control (black) conditions
at times indicated by the letters.
(B) L-LTP was also blocked by epoxomicin (10 nM), an inhibitor of
proteasome-dependent protein degradation. LTP values for epoxo-
micin-treated slices (filled light blue squares) were significantly
lower than control values (filled black symbols) at the end of the re-
cording (117% 6 6%, n = 7, compared with 162% 6 4%, n = 30; p <
0.001; green triangles denote p values). A second independent con-
trol pathway was recorded simultaneously, showing no decrement
in basal synaptic transmission (open symbols).
(C) Protein synthesis inhibitors effectively block L-LTP. LTP was in-
duced in the presence of anisomycin (25 mM), a reversible translation
blocker. LTP values for anisomycin-treated slices (filled orange
squares) were significantly lower than for control slices (filled black
circles) at the end of the recording (128% 6 3%, n = 18, compared
with 162%6 4%, n = 30; p < 0.001; green triangles denote p values).
A second, independent control pathway was recorded simulta-
neously, showing no decrement in basal synaptic transmissionn = 9; filled black circles, control: 167%6 4%, n = 30; p =
0.80; 50–60 min after tetanus; green triangles denote p
values of the difference between lactacystin and control;
for details of the analysis see Experimental Procedures),
L-LTP was significantly reduced (Figure 1A; filled blue
squares, lactacystin: 140% 6 5%, n = 9; filled black
circles, control: 162% 6 4%, n = 30; p = 0.002; 200–
210 min). A separate control pathway (Figure 1A, open
symbols) showed no decrement, indicating that lacta-
cystin application had no effect on basal synaptic trans-
mission. Therefore, the effects of the blockade of protein
degradation specifically affected potentiated synapses.
To confirm the effect on L-LTP by proteasomal blockade
using lactacystin, we also used epoxomicin (10 nM),
another inhibitor of proteasome-dependent protein de-
gradation. Application of epoxomicin resulted in a very
similar effect: L-LTP was significantly diminished, even
more strongly than in the case of lactcystin (Figure 1B;
filled light blue squares, epoxomicin: 117% 6 6%, n =
7; filled black circles, control: 162% 6 4%, n = 30;
p < 0.001; 200–210 min). Again, a second independent
control pathway was recorded simultaneously, showing
no decrement in basal synaptic transmission (open
symbols).
L-LTP Blockade by Protein Synthesis Inhibition
Can Be Counteracted by Proteasome Inhibition
Consistent with the literature (Frey et al., 1988; Huang
et al., 1996), we found that the application of anisomy-
cin, a translation inhibitor, blocked L-LTP (Figure 1C,
data in part from Fonseca et al., 2006). L-LTP values
for anisomycin-treated slices (filled orange squares)
were significantly lower than for control slices (filled
black circles) (128% 6 3%, n = 18; compared with
162% 6 4%, n = 30; p < 0.001; 200–210 min). Similar to
the case of lactacystin, no decrement was observed
for the separate control pathway, indicating that the ef-
fect of protein synthesis blockade is specific to potenti-
ated synapses.
In order to explore the role of protein degradation un-
der conditions when no protein synthesis is possible, we
tested the effect of coapplying anisomycin and lacta-
cystin during the induction of LTP. Both drugs were
again bath-applied 40 min before and washed out 1 hr
after LTP induction (Figure 2A). We observed that lacta-
cystin neutralized the effect of anisomycin. L-LTP values
for the anisomycin/lactacystin-treated slices (filled green
diamonds) were indistinguishable from the controls
(filled black circles) (anisomycin/lactacystin: 162% 6
5%, n = 9; control: 162% 6 4%, n = 30; p = 0.95; 200–
210 min). Comparison with Figure 1C shows that LTP
values for anisomycin/lactacystin-treated slices were
indeed significantly higher than for anisomycin alone
(Figure 2A, anisomycin/lactacystin: 162% 6 5%, n = 9;
Figure 1C, anisomycin: 128% 6 3%, n = 8; p < 0.001).
These data indicate that blockade of protein synthesis
does not diminish L-LTP, provided that protein degrada-
tion is also inhibited.
To rule out the possibility that this result was due to
some particularity of the drugs used, we performed
(open symbols). The data for the anisomycin experiments in this
panel were published previously (Fonseca et al., 2006).
Inset scale bars, 1 mV, 10 ms. Error bars = SEM.
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241the same experiments using emetine, which is known
to block L-LTP (Stanton and Sarvey, 1984; Bradshaw
et al., 2003), as the protein synthesis inhibitor instead
of anisomycin. We induced LTP in the presence of eme-
tine (25 mM) alone or together with lactacystin (10 nM).
Both drugs were bath-applied 40 min before and
washed out 1 hr after LTP induction. LTP values for the
emetine/lactacystin-treated slices (Figure 2C, filled
Figure 2. Simultaneous Blockade of Protein Degradation and
Protein Translation Lead to Rescue of L-LTP
(A) Concurrent application of lactacystin and anisomycin rescues
L-LTP. LTP was induced in the presence of both anisomycin
(25 mM) and lactacystin (10 nM). LTP values in anisomycin/lactacys-
tin- (filled green diamonds) treated slices were not significantly
different from those obtained in control experiments (162% 6 5%,
n = 9, compared with 162% 6 4%, n = 30; p = 0.95; green triangles
denote p values).
(B) Concurrent application of anisomycin and epoxomicin rescues
L-LTP. When LTP was induced in the presence of anisomycin and
epoxomicin (filled brown squares), no decrement was observed at
any time throughout the recording time compared to controls (filled
black circles), including at the end of the recording (200–210 min)
(142% 6 13%, n = 7, compared with 162% 6 4%, n = 30; p = 0.17).
(C) Emetine (25 mM) coapplied with lactacystin (10 nM) (purple
diamonds) shows an effect similar to the anisomycin/lactacystin
experiment (emetine/lactacystin: 142% 6 6%, n = 7, compared
with emetine alone: 107% 6 9%, n = 6; p = 0.01).
Inset scale bars, 1 mV, 10 ms. Error bars = SEM.purple diamonds; emetine/lactacystin: 142% 6 6%,
n = 7) were in this case significantly lower than for con-
trols (Figure 2C, filled black circles; control: 162% 6
4%, n = 30; p = 0.01) at the end of the recording, but sig-
nificantly higher than for slices treated only with emetine
(Figure 2C, filled purple diamonds; emetine/lactacystin:
142% 6 6%, n = 7; filled red squares, emetine: 107% 6
9%, n = 6; p = 0.01). Therefore, while the effect was
quantitatively reduced with emetine, there was still
a qualitative and significant rescue of L-LTP that oc-
curred when protein degradation had been blocked by
lactacystin. Finally, to confirm the findings we used an-
other blocker of the proteasome, epoxomicin, and
checked whether it could also rescue the effect of aniso-
mycin on L-LTP. Epoxomicin (10 nM) in combination
with anisomycin (25 mM) yielded results that mirrored
the effects we observed when proteasomal activity was
impaired by lactacystin (Figure 2B; filled brown dia-
monds, anisomycin/epoxomicin: 142% 6 13%, n = 7;
filled black circles, control: 162%6 4%, n = 30; p = 0.17).
To make the data more comparable, we also chose
a different way to display the data and normalized
them on the magnitude of LTP in the respective experi-
ment (Figure 3). This way of displaying the data shows
clearly that lactacystin, epoxomicin, anisomycin, and
emetine have very similar effects of diminishing LTP,
whereas the combinations of anisomycin/lactacystin,
emetine/lactacystin, and anisomycin/epoxomicin are al-
most indistinguishable from controls; i.e., the effects of
anisomycin/emetine and lactacystin/epoxomicin almost
completely compensate each other.
Biochemical Confirmation of Drug Effects
We confirmed that the bath application of 10 nM lacta-
cystin or 10 nM epoxomicin impairs the activity of the
proteasome in hippocampal slices. To this end, we
performed biochemical experiments determining the
expected accumulation of polyubiquitinated proteins
following proteasome blockade (Figure 4A; see Experi-
mental Procedures for details). In two experiments, a
Figure 3. Summary Plot Showing the Decay of LTP in Different
Conditions
Percentage of decay of LTP values was determined by the ratio be-
tween 10 min data bins shortly after LTP induction (indicated by [1] in
Figure 1A) and 10 min data bins at the end of the recording (indicated
by [2] in Figure 1A), ([1]-[2])/[2]3100%). Control values were aver-
aged between all control experiments. Proteasome and translation
blockers alone all strongly block L-LTP (columns 5–8), whereas con-
current application of both rescues L-LTP (columns 2–4). Error
bars = SEM.
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242Figure 4. Biochemical and Electrophysiolog-
ical Control Experiments
(A) Western blotting reveals an accumulation
of polyubiquitinated protein species when
lactacystin (10 nM), epoxomicin (10 nM), or
MG132 (20 mM) is applied to hippocampal sli-
ces compared over control conditions or
when anisomycin (25 mM) is applied alone
(see text for quantification).
(B) [35S]-methionine incorporation in slices
treated with the protein synthesis inhibitor
anisomycin demonstrates that protein syn-
thesis is effectively blocked. Slices were
incubated in anisomycin (25 mM) and [35S]-
methionine and selected at 20, 40, and
60 min. Amino acid incorporation was
assessed by autoradiographic exposure of
SDS-PAGE gels. Coapplication of lactacystin
did not alter the translation inhibition induced
by anisomycin application alone. The bands
toward the bottom of the gel may in part
originate from free radioactive methionine; al-
ternatively, they may derive from peptide
fragments or methionine-tRNA.
(C) Coomassie blue-stained gel from experi-
ments shown in (B) shows that similar
amounts of protein were loaded in the differ-
ent lanes of the SDS-PAGE gel. The numbers
on the left indicate the molecular weight in
kDa of the bands of the molecular weight
marker.
(D and E) Neither lactacystin nor lactacystin in
combination with anisomycin altered basal
synaptic transmission in slice hippocampal
neurons. (D) Input/output curve for control,
lactacystin-, and lactacystin/anisomycin-
treated slices. After 40 min of bath applica-
tion of the drugs, fEPSP amplitudes were
measured in response to increasingly intense
stimulation of the afferents by current in-
jections in steps of 20 mA. No significant
differences were obtained for the three con-
ditions tested. (E) Paired-pulse facilitation, as assessed by fEPSP responses for 10, 20, 40, 80, and 160 ms interstimulus intervals, was not dif-
ferent from control (black circles, n = 6) under lactacystin (blue squares, n = 5) or under lactacystin/anisomycin (green diamonds, n = 5).
(F and G) A different analysis yields similar results. (F) Integral analysis of fEPSP responses before and after LTP induction in lactacystin-treated and
control slices qualitatively yielded the same results as the slope analysis. The areas were measured as indicated in the inset diagram. Data repre-
sent 10 min data bins, at time indicated, normalized to the initial 20 min of baseline recordings. Lactacystin did not affect the fEPSP integral in the
control nonpotentiated pathway throughout the recording time (210 min) (open symbols). (G) Integral analysis of fEPSPs for control (black circles,
n = 30), lactacystin/anisomycin-(green diamonds, n = 9), and lactacystin/emetine-(purple diamonds, n = 7) treated slices. n, number of slices.
Error bars = SEM.small but consistent accumulation of polyubiquitinated
protein species in slices incubated with the proteasome
inhibitors was observed (Figure 4A; normalized pixel
values for experiment 1: 148%, lacta; 149%, epox; 99%,
ani; 120%, MG132; and 100%, control; normalized pixel
values for experiment 2 [data not shown]: 112%, lacta;
132%, epox; and 100%, control). This indicates that
proteasome-dependent degradation was indeed im-
paired when lactacystin or epoxomicin had been applied.
In order to prove conclusively that L-LTP can occur in
the absence of the production of new proteins, it is
essential to verify that no protein synthesis is occurring
under our experimental conditions. To this end, we
assayed protein synthesis directly by measuring radio-
active amino acid incorporation under the same ex-
perimental conditions. Acute hippocampal slices were
prepared and treated exactly as they were for the elec-
trophysiological experiments. Anisomycin (25 mM) alone
and anisomycin (25 mM) together with lactacystin
(10 nM) were bath-applied in the presence of 10 mCi/mlof [35S]-methionine. Slices were lysed after 20, 40, and
60 min, and the amino acid incorporation was assessed
by autoradiography (see Experimental Procedures).
No [35S]-methionine incorporation (Figure 4B) was de-
tected, although similar amounts of protein were loaded
in the different lanes of the SDS-PAGE gel (Figure 4C),
demonstrating that translation was effectively blocked
under our experimental conditions. Similarly, the aniso-
mycin/lactacystin condition showed no signs of appre-
ciable [35S]-methionine incorporation, ruling out any
nonspecific effects of the combination of drugs. These
effects were confirmed with a different translational
blocker (25 mM emetine; see Figure S1 in the Supple-
mental Data).
Further Controls
To check whether blocking the proteasome acutely af-
fects basal synaptic transmission in slice hippocampal
neurons, we carried out several electrophysiological
analyses. We measured input/output curves for control,
Role of Protein Synthesis and Degradation in L-LTP
243lactacystin-, and lactacystin/anisomycin-treated slices
(Figure 4D). After 40 min of bath application of the drugs,
field excitatory postsynaptic potential (fEPSP) ampli-
tudes were measured in response to increasingly in-
tense stimulation of the afferents by current injections
in steps of 20 mA. No significant differences were ob-
tained for the three conditions tested. We also assessed
paired-pulse facilitation, measuring fEPSP responses
for 10, 20, 40, 80, and 160 ms interstimulus intervals,
which were not affected significantly by lactacystin or
anisomycin/lactacystin (Figure 4E).
Moreover, we reanalyzed our data by measuring
the integral (‘‘area under the curve’’) of the fEPSP
responses before and after LTP induction in control, lac-
tacystin-, emetine/lactacystin-, and anisomycin/lacta-
cystin-treated slices. Indeed, the integral analysis qual-
itatively yielded the same results as the slope analysis,
indicating that the drug effects are robust (Figures 4F
and 4G). Finally, we performed repeated measures
ANOVA on the data set from the slope analysis, which
fully confirm our conclusions (see Table S1 in the Sup-
plemental Data).
Discussion
The experiments described above have two major
results. First, they show that interfering with the de-
gradation of proteins—just like interfering with their
production—strongly diminishes L-LTP. Second, they
make the surprising point that protein synthesis is
not an absolute requirement for L-LTP. Therefore,
models that only consider the effects of protein synthe-
sis for L-LTP need to be amended to include protein
degradation.
Even though the observation that proteasome inhibi-
tion results in an impairment in L-LTP could at first
glance be considered as surprising (but see recent re-
port by Karpova et al., 2006), there are several studies
in the literature that are in line with this finding. Protea-
some inhibition was shown to block long-term memory
formation in rodents (Lopez-Salon et al., 2001) and
long-term facilitation in Aplysia (Chain et al., 1995,
1999). Moreover, mice with maternal deficiency due to
a mutation in the E6-AP ubiquitin ligase have impaired
LTP, providing genetic evidence for the role of ubiquiti-
nation in synaptic enhancement (Jiang et al., 1998). In
addition, ubiquitination has been reported to mediate
long-term depression (LTD), marking PSD-95 for re-
moval from synaptic sites in response to NMDA receptor
activation and low-frequency synaptic stimulation (Col-
ledge et al., 2003). Furthermore, AMPA-induced AMPA
receptor internalization is blocked by brief applications
of proteasome inhibitors (Patrick et al., 2003). Finally,
there is evidence that synaptic growth and function at
the Drosophila neuromuscular junction depend on
proper levels of ubiquitination (DiAntonio et al., 2001).
These findings point to a key role of proteasome-depen-
dent protein degradation in synaptic plasticity. The pos-
sibility that degradation of synaptic proteins might be
under activity-dependent control is further supported
by recent work from our group showing that the decay
of LTP during protein synthesis blockade depends
strongly on the level of synaptic activation that the po-
tentiated synapses experience (Fonseca et al., 2006).The fact that proper functioning of the proteasome is
required for the maintenance of LTP argues against
a simple model in which ‘‘positive’’ effector proteins
alone are upregulated after LTP induction. In this case
blocking protein degradation would be expected to en-
hance LTP. A scenario more consistent with the experi-
ments described above assumes a critical role of ‘‘neg-
ative’’ effector proteins, which would normally be
targeted for degradation after LTP induction, thereby
unmasking the action of the positive effector proteins.
Figure 5 shows a model that illustrates the effects of
blocking protein synthesis and degradation separately
or at the same time. In the presence of drugs that block
protein synthesis, any production of positive and nega-
tive plasticity proteins after LTP induction is prevented,
leading to diminished L-LTP levels. Under these con-
ditions the time course of LTP should reflect the shift-
ing balance between the levels of the preexisting pool
of positive and negative effector proteins and their
Figure 5. A Model of the Role of Protein Synthesis and Degradation
for L-LTP
(A) When protein synthesis and degradation are intact, L-LTP, indi-
cated by the yellow rectangle, is sustained by the combined action
of the synthesis of ‘‘positive’’ proteins and the degradation of ‘‘neg-
ative’’ proteins. Positive and negative proteins derive from a pool of
preexisting proteins and a pool of de novo synthesized proteins. The
effect of the positive proteins is indicated by the green triangles and
the effect of the negative proteins by the red triangles. The color
gradient indicates their time course after LTP induction due to
synthesis and degradation. The preexisting proteins are instantly
activated by the LTP induction.
(B) When protein translation of positive and negative plasticity pro-
teins is blocked (gray triangles), L-LTP (gray rectangle) is dimin-
ished, despite preexisting positive proteins, which are subject to
degradation (indicated by the graded green triangle).
(C) When proteasome-dependent degradation is blocked, L-LTP is
reduced due to the persistence of the negative proteins (red trian-
gles), which counteract the effects of the positive proteins (green
triangles).
(D) When protein synthesis and degradation are blocked at the
same time, L-LTP is made possible by the persistent dominance
of the preexisting positive proteins over the preexisting negative
proteins.
Neuron
244degradation. In the presence of lactacystin/epoxomicin,
which block protein degradation, the negative effector
proteins would not be degraded, leading to a reduction
in L-LTP expression. This scenario is along the lines of
what has been shown in studies of Aplysia LTF (Hegde
et al., 1993, 1997; Chain et al., 1995), which showed
that proteasome-dependent degradation is responsible
for the loss of an inhibitory regulatory subunit of the pro-
tein kinase A (PKA), which disinhibits LTF. The scenario
is also consistent with the rescue effect observed when
protein degradation was blocked pharmacologically at
the same time as protein synthesis. In this case, the pre-
existing pool of positive effector proteins would be suf-
ficient to ensure synaptic potentiation. Testing this
model further will most likely require knowing the iden-
tity of the positive and negative effector proteins in order
to manipulate their activity and/or expression levels
separately. Interestingly, a recent paper concludes
that associative learning in Drosophila triggers a protea-
some-mediated release of suppression of gene expres-
sion of synaptic proteins that are associated with a sta-
ble memory (Ashraf et al., 2006), raising the possibility
that the regulation of the proteasome plays a major
and largely unexplored role in shaping neuronal circuits
important for learning and memory. Furthermore, it has
been shown that growth cone responses in axon guid-
ance (Campbell and Holt, 2001) and the plasticity of
Aplysia sensory-motor synapses (Zhao et al., 2003) are
determined by the balance of protein synthesis and pro-
tein degradation.
While our model is certainly an oversimplification of
the cell biological dynamics of protein synthesis and
degradation, it correctly captures the drug effects on
L-LTP we observed.
The outcome of the experiment in which anisomycin/
emetine and lactacystin/epoxomicin were applied si-
multaneously has important consequences for the cur-
rent thinking on long-term synaptic plasticity. It is widely
believed that the late phase of LTP critically depends on
protein synthesis being intact (Huang et al., 1996; Barco
et al., 2002; Calixto et al., 2003; Cammalleri et al., 2003).
This conclusion is based on the fact that translational
blockers in a number of different experimental settings
inhibited L-LTP while leaving the early component of
LTP unaffected. Although this conclusion seems rea-
sonable at first glance, our experiments show that it is
not necessarily warranted. Protein synthesis is indeed
needed when protein degradation is functional. How-
ever, when protein degradation is blocked, the require-
ment for de novo protein synthesis becomes obsolete,
suggesting that synapses are constitutively endowed
with the necessary molecular components to support
even longer lasting changes in synaptic strength.
Experimental Procedures
Slice Preparation, Electrophysiological Recordings,
and Analysis
The detailed procedure for acute hippocampal slice preparation and
recording of extracellular fEPSPs has been described elsewhere
(Fonseca et al., 2004). Briefly, 400 mm thick brain slices were acutely
prepared from male Wistar rats (3 to 4 weeks old). Recordings
started after a 20 min resting period in the recording chamber main-
tained at 32C. Schaffer collaterals were stimulated with 0.2 ms
pulses using monopolar tungsten electrodes. Stimulus intensitieswere set to evoke 50% of the maximal fEPSP slope and LTP was in-
duced after recording a stable baseline of fEPSPs for 40 min. The
test pulse frequency was 0.1 Hz. Two stimulating electrodes were
positioned in the stratum radiatum, allowing us to stimulate two in-
dependent sets of Schaffer collaterals. For any given drug or drug
combination, the experiments were interleaved with control experi-
ments in a blind fashion. After baseline stimulation, one of the path-
ways was arbitrarily chosen to receive tetanic stimulation of 100 Hz
for 1 s. The control pathway was monitored continuously, allowing
us to assess the overall health of the slice. Experiments were re-
jected if the control pathways had decayed more than 30% below
baseline. The fraction of rejected experiments was comparable for
the various drug and control conditions. Offline data analysis was
performed using a customized LabView-program (National Instru-
ments). As a measure of synaptic strength, the initial slope of the
evoked fEPSPs was calculated and expressed as a percent change
from the baseline mean. Error bars in figures denote SEM values. To
test for group differences between LTP values across conditions,
a two-tailed Student’s t test was used (green triangles indicate
p values). To this end, LTP values were averaged into 10 min data
bins. In addition, we performed repeated measures ANOVA across
the drug conditions; the time windows are detailed in Table S1.
The effects of the various drug combinations were statistically
tested against drug-free control experiments that were carried out
in an interleaved and blindfolded way for each of the experimental
conditions. For the figures, we pooled all the controls from all the ex-
perimental series and show the overall control values for the pooled
dataset as well as the associated p values. We verified that the other
way of testing the data (comparing control and experiment within
each data set) led to the same results (data not shown).
Proteasome and Protein Synthesis Inhibitors
Lactacystin and epoxomicin (Sigma, Munich, Germany) were dis-
solved in DMSO and diluted down to achieve a final concentration
of 10 nM (in 0.01% DMSO). Anisomycin and emetine (Sigma) were
dissolved in DMSO and diluted down to achieve a final concentra-
tion of 25 mM (in 0.01% DMSO). All drugs were bath-applied for
40 min before and washed out 1 hr after LTP induction. For the con-
trol experiments only, DMSO (0.01%) was added to the artificial
cerebrospinal fluid (ACSF).
Assessment of Blockade of Protein Synthesis and Degradation
To assess whether emetine and anisomycin, at the concentration
used and under the circumstances of our experiments, reliably block
protein synthesis (Stanton and Sarvey, 1984; Rosenblum et al., 1993),
we measured the incorporation of [35S]-methionine into newly syn-
thesized proteins. Hippocampal slices were prepared following the
same procedure as detailed for the electrophysiological experi-
ments. After an hour-long resting phase, slices were transferred to
an incubation chamber at 32C. After an equilibration period of
10 min, anisomycin (25 mM), emetine (25 mM), and anisomycin
(25 mM)/lactacystin (10 nM) were bath-applied with 10 mCi/ml of [35S]-
methionine (Amersham Biosciences, Munich, Germany). For analy-
sis of translational activity, slices were collected 20, 40, and 60 min
after adding the drugs and the radioactive agent and lysed in pre-
heated lysis buffer (125 mM TrisHCl [pH 6.8], 2% SDS, 25% glycerol,
200 mM DTT). DNA was sheared, and lysates were centrifuged at
14,000 r.p.m. for 10 min. Protein concentration was determined using
Coomassie Protein Assay Reagent Kit (Pierce, Bonn, Germany).
Equal amounts of protein were separated in 10% SDS-PAGE. To
assess total protein, gels were stained with Coomassie blue, de-
stained, and scanned. Subsequently, the gels were dried and ex-
posed to the radioactivity screen. Images were scanned and ana-
lyzed using FLA-2000 Image analyzer (FujiFilm) and AIDA software
(Raytest).
To analyze proteasome activity, hippocampal slices were incu-
bated with lactacystin (10 nM) and epoxomicin (10 nM) for 2 hr. In
addition to the drug-free control, we used MG132 (20 mM), another
inhibitor of the proteasome, as a positive control. Subsequently,
their lysates were prepared and western blotted against polyubiqui-
tin (monoclonal antibody clone P4D1, Santa Cruz Biotechnology,
Santa Cruz, CA). The intensity of each band (averaged over equal
areas for all conditions) was normalized by the signal from an
Role of Protein Synthesis and Degradation in L-LTP
245antibody against GAPDH (Chemicon, Temecula, CA) to account for
differences in gel loading for the various conditions.
Supplemental Data
The Supplemental Data for this article can be found online at http://
www.neuron.org/cgi/content/full/52/2/239/DC1/.
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